DreamCIS Inc
DreamCIS, Inc. operates as a clinical research organization in South Korea. It offers clinical development services; biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headqua… Read more
DreamCIS Inc (223250) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.023x
Based on the latest financial reports, DreamCIS Inc (223250) has a cash flow conversion efficiency ratio of 0.023x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.17 Billion) by net assets (₩92.81 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DreamCIS Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how DreamCIS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
DreamCIS Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DreamCIS Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SNU Precision Co. Ltd
KQ:080000
|
0.008x |
|
MOTORK LTD. EO -01
F:5FS
|
N/A |
|
IKIO Lighting Limited
NSE:IKIO
|
0.009x |
|
Beijing Energy International Holding Co. Ltd
PINK:PVLTF
|
0.028x |
|
Tambun Indah Land Bhd
KLSE:5191
|
0.055x |
|
Shree Rama Multi-Tech Limited
NSE:SHREERAMA
|
0.161x |
|
DevvStream Holdings Inc.
OTCQB:DSTRF
|
0.071x |
|
CammSys Corp
KQ:050110
|
0.139x |
Annual Cash Flow Conversion Efficiency for DreamCIS Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of DreamCIS Inc from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩67.96 Billion | ₩-85.19 Million | -0.001x | -100.97% |
| 2023-12-31 | ₩56.93 Billion | ₩7.33 Billion | 0.129x | -30.57% |
| 2022-12-31 | ₩48.96 Billion | ₩9.08 Billion | 0.186x | +19.79% |
| 2021-12-31 | ₩37.98 Billion | ₩5.88 Billion | 0.155x | +65.10% |
| 2020-12-31 | ₩36.46 Billion | ₩3.42 Billion | 0.094x | -76.46% |
| 2019-12-31 | ₩10.75 Billion | ₩4.28 Billion | 0.398x | -46.58% |
| 2018-12-31 | ₩6.51 Billion | ₩4.85 Billion | 0.746x | +27.42% |
| 2017-12-31 | ₩2.82 Billion | ₩1.65 Billion | 0.585x | -- |